The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Matinas BioPharma Holdings, Inc(NYSE MKT:MTNB)

Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nano-crystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crysta...
Website: http://www.matinasbiopharma.com
Founded: 2013
Full Time Employees: 21
Sector: Healthcare
Industry: Biotechnology
Matinas BioPharma Days Payable Outstanding ttm (DPO)
Matinas BioPharma Op Cashflow Per Share ttm
Matinas BioPharma Free Cashflow Per Share ttm
Matinas BioPharma Cash Per Share ttm
Matinas BioPharma P/S ratio ttm
Matinas BioPharma (GAAP) P/E ratio ttm
Matinas BioPharma P/B ratio ttm
No extra charts and metrics for this ticker.